TY - JOUR AU - Al Sawah, S. AU - Zhang, X. AU - Zhu, B. AU - Magder, L. S. AU - Foster, S. A. AU - Iikuni, N. PY - 2015 DA - 2015// TI - Effect of corticosteroid use by dose on the risk of developing organ damage over time in systemic lupus erythematosus—the Hopkins Lupus Cohort JO - Lupus Sci Med VL - 2 UR - https://doi.org/10.1136/lupus-2014-000066 DO - 10.1136/lupus-2014-000066 ID - Al Sawah2015 ER - TY - JOUR AU - Gladman, D. D. AU - Urowitz, M. B. AU - Rahman, P. AU - Ibañez, D. AU - Tam, L. -. S. PY - 2003 DA - 2003// TI - Accrual of organ damage over time in patients with systemic lupus erythematosus JO - J Rheum VL - 30 ID - Gladman2003 ER - TY - JOUR AU - Petri, M. AU - Purvey, S. AU - Fang, H. AU - Magder, L. S. PY - 2012 DA - 2012// TI - Predictors of organ damage in systemic lupus erythematosus: the Hopkins lupus cohort JO - Arthritis Rheum VL - 64 UR - https://doi.org/10.1002/art.34672 DO - 10.1002/art.34672 ID - Petri2012 ER - TY - JOUR AU - Thamer, M. AU - Hernán, M. AU - Zhang, Y. AU - Cotter, D. AU - Petri, M. PY - 2009 DA - 2009// TI - Prednisone, lupus activity, and permanent organ damage JO - J Rheum VL - 36 UR - https://doi.org/10.3899/jrheum.080828 DO - 10.3899/jrheum.080828 ID - Thamer2009 ER - TY - JOUR AU - Zonana-Nacach, A. AU - Barr, S. G. AU - Magder, L. S. AU - Petri, M. PY - 2000 DA - 2000// TI - Damage in systemic lupus erythematosus and its association with corticosteroids JO - Arthritis Rheum VL - 43 UR - https://doi.org/3.0.CO;2-O DO - 3.0.CO;2-O ID - Zonana-Nacach2000 ER - TY - JOUR AU - Bexelius, C. AU - Wachtmeister, K. AU - Skare, P. AU - Jönsson, L. AU - Vollenhoven, R. PY - 2013 DA - 2013// TI - Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports JO - Lupus VL - 22 UR - https://doi.org/10.1177/0961203313491849 DO - 10.1177/0961203313491849 ID - Bexelius2013 ER - TY - STD TI - European Medicines Association. Guideline on clinical investigation of medicinal products for the treatment of systemic lupus erythematosus, cutaneous lupus and lupus nephritis. 2013. http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500139615&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc. Accessed Apr 2015. UR - http://www.ema.europa.eu/ema/doc_index.jsp?curl=pages/includes/document/document_detail.jsp?webContentId=WC500139615&murl=menus/document_library/document_library.jsp&mid=0b01ac058009a3dc ID - ref7 ER - TY - JOUR AU - Vollenhoven, R. F. AU - Mosca, M. AU - Bertsias, G. AU - Isenberg, D. AU - Kuhn, A. AU - Lerstrom, K. PY - 2014 DA - 2014// TI - Treat-to-target in systemic lupus erythematosus: recommendations from an international task force JO - Ann Rheum Dis VL - 73 UR - https://doi.org/10.1136/annrheumdis-2013-205139 DO - 10.1136/annrheumdis-2013-205139 ID - Vollenhoven2014 ER - TY - JOUR AU - Berti, D. AU - Moons, P. AU - Dobbels, F. AU - Deuson, R. AU - Janssens, A. AU - Geest, S. PY - 2008 DA - 2008// TI - Impact of corticosteroid-related symptoms in patients with immune thrombocytopenic purpura: results of a survey of 985 patients JO - Clin Ther VL - 30 UR - https://doi.org/10.1016/j.clinthera.2008.08.005 DO - 10.1016/j.clinthera.2008.08.005 ID - Berti2008 ER - TY - JOUR AU - Holloway, L. AU - Humphrey, L. AU - Heron, L. AU - Pilling, C. AU - Kitchen, H. AU - Hojbjerre, L. PY - 2014 DA - 2014// TI - Patient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performance JO - Health Qual Life Out VL - 12 UR - https://doi.org/10.1186/s12955-014-0116-1 DO - 10.1186/s12955-014-0116-1 ID - Holloway2014 ER - TY - STD TI - Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims 2009. 2009. Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf. Accessed Apr 2015. UR - http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf ID - ref11 ER - TY - JOUR AU - Hochberg, M. C. PY - 1997 DA - 1997// TI - Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus JO - Arthritis Rheum VL - 40 UR - https://doi.org/10.1002/art.1780400928 DO - 10.1002/art.1780400928 ID - Hochberg1997 ER - TY - JOUR AU - Mathias, S. D. AU - Berry, P. AU - DeVries, J. AU - Askanase, A. AU - Pascoe, K. AU - Colwell, H. PY - 2015 DA - 2015// TI - Development of Two novel patient reported outcome (PRO) measures: the systemic lupus erythematosus (SLE) symptom severity diary (SSD) and SLE impact questionnaire (SIQ) JO - Annals Rheum Dis VL - 74 ID - Mathias2015 ER - TY - JOUR AU - Sarnes, E. AU - Crofford, L. AU - Watson, M. AU - Dennis, G. AU - Kan, H. AU - Bass, D. PY - 2011 DA - 2011// TI - Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review JO - Clin Ther VL - 33 UR - https://doi.org/10.1016/j.clinthera.2011.09.009 DO - 10.1016/j.clinthera.2011.09.009 ID - Sarnes2011 ER - TY - JOUR AU - Manson, S. C. AU - Brown, R. E. AU - Cerulli, A. AU - Vidaurre, C. F. PY - 2009 DA - 2009// TI - The cumulative burden of oral corticosteroid side effects and the economic implications of steroid use JO - Respir Med VL - 103 UR - https://doi.org/10.1016/j.rmed.2009.01.003 DO - 10.1016/j.rmed.2009.01.003 ID - Manson2009 ER - TY - JOUR AU - Lim, S. S. AU - Bayakly, A. R. AU - Helmick, C. G. AU - Gordon, C. AU - Easley, K. A. AU - Drenkard, C. PY - 2014 DA - 2014// TI - The incidence and prevalence of systemic lupus erythematosus, 2002–2004: the Georgia lupus registry JO - Arthritis Rheumatol VL - 66 UR - https://doi.org/10.1002/art.38239 DO - 10.1002/art.38239 ID - Lim2014 ER -